Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 16.13 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $7.604 million which beat the analyst consensus estimate of $6.550 million by 16.09 percent. This is a 23.74 percent increase over sales of $6.145 million the same period last year.